Skip to content

SMASHING in adults Self-Management of Asthma Supported by Hospitals, Information and communication technology, Nurses and General practitioners.

SMASHING in adults Self-Management of Asthma Supported by Hospitals, Information and communication technology, Nurses and General practitioners: a randomised controlled trial.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON20415
Enrollment
250
Registered
2005-11-15
Start date
2006-01-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

A 12-month intervention period where the patients receive either ‘usual care’ or ‘ICT-supported care’ guided by a specialised asthma nurse and doctor. Care strategies (1) Usual care According to th

Sponsors

- Leiden University Medical Center - ZonMW, The Hague
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. 250 patients with mild persistent to moderate asthma (prevalent cases); 2. Age 18-50 yr; 3. Doctors diagnosis of asthma; 4. Asthma severity step 2-3, patients who need inhaled corticosteroids as controller medication (at least 3 months in the past year); 5. PC with internet connection available; 6. Able to communicate in the Dutch language.

Exclusion criteria

Exclusion criteria: 1. Patients with intermittent asthma; 2. Patients with severe asthma; 3. Use of oral glucocorticosteroids as controller medication; 4. Serious co-morbidity interfering with asthma or treatment of asthma; 5. No PC or no internet connection; 6. Not able to communicate in the Dutch language.

Design outcomes

Primary

MeasureTime frame
1. Asthma related quality of life; 2. Measurement instrument: AQLQ (asthma quality of life questionnaire); 3. Evaluation at baseline, after 3 months and after 12 months.

Secondary

MeasureTime frame
1. Asthma control; 2. Symptom free days; 3. Exacerbations; 4. Health care utilisation; 5. Absence of work/school; 6. Lung function; 7. Exhaled nitric oxide; 8. Medication use; 9. Side effects.

Contacts

Public ContactVictor Meer, van der

Leiden University Medical Center (LUMC), Department of Medical Decision Making, J-10-87, P.O. Box 9600

V.van_der_Meer@lumc.nl+31 (0)71 5264904

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)